| Alkyl chain modified imidazoquinoline TLR7/8 agonist compounds and uses thereof |
2023-7-26 |
2023-9-14 |
|
| Cleavable conjugate of tlr7/8 agonist compound, method for preparing the same, … |
2023-4-25 |
2023-7-11 |
|
| Immunogenic compositions comprising a recombinant neuraminidase and cpg … |
2023-2-28 |
2023-10-12 |
|
| Immunogenic composition against severe acute respiratory syndrome coronavirus 2 … |
2023-1-17 |
2023-4-27 |
|
| Immunogenicity of a cpg-adjuvanted herpes zoster vaccine |
2022-12-22 |
2023-6-29 |
|
| VACCINE AGAINST SARS-CoV-2 VIRUS WITH CpG ADJUVANT |
2022-9-16 |
2022-10-31 |
|
| Active immunization against tetanus, diphtheria and pertussis. |
2022-9-08 |
2023-6-23 |
|
| Toll-like receptor antagonist compounds and methods of use |
2022-5-20 |
2022-9-22 |
|
| Method for quantifying cpg-containing oligonucleotides in formulations … |
2021-12-14 |
2023-10-25 |
|
| Immunogenic composition against severe acute respiratory syndrome coronavirus 2 … |
2021-6-18 |
2023-1-01 |
|
| IMMUNOGENIC COMPOSITION AGAINST SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 … |
2021-6-18 |
2021-10-07 |
|
| Combination including a cpg-c type oligonucleotide and a pd-1 antagonist for … |
2021-4-13 |
2021-10-14 |
|
| CpG-adjuvanted SARS-CoV-2 virus vaccine |
2021-4-06 |
2023-1-31 |
|
| Cpg-adjuvanted sars-cov-2 virus vaccine |
2021-4-06 |
2021-10-20 |
|
| Shingles vaccines comprising a tlr9 agonist |
2021-3-09 |
2021-9-16 |
|
| Production of vaccines comprising inactivated sars-cov-2 viral particles |
2021-3-05 |
2021-9-10 |
|
| Coronavirus vaccines comprising a tlr9 agonist |
2021-3-01 |
2023-8-09 |
|
| Coronavirus vaccines comprising a tlr9 agonist |
2021-3-01 |
2023-9-13 |
|
| Combination of a pd-1 antagonist and cpg-c type oligonucleotide for treating … |
2020-8-21 |
2021-7-01 |
|
| Combinations including a cpg-c type oligonucleotide and a histone deacetylase … |
2019-4-12 |
2019-10-17 |
|
| Immunostimulatory sequence oligonucleotides and methods of using the same |
2018-12-18 |
2022-4-26 |
2022-4-26 |
| Administration of polynucleotide toll-like receptor 9 agonists for treating … |
2018-9-25 |
2019-5-23 |
|
| Branched chimeric compounds, and methods of use thereof |
2018-4-20 |
2019-8-08 |
|
| Methods and compositions for eliciting an immune response against hepatitis B … |
2018-1-18 |
2019-6-11 |
2019-6-11 |
| Intratumoral administration of particles containing a toll-like receptor 9 … |
2017-4-14 |
2019-2-14 |
|
| Combination of an anti-il-10 antibody and a cpg-c type oligonucleotide for … |
2016-5-26 |
2018-6-14 |
|
| Human toll-like receptor inhibitors and methods of use thereof toll |
2016-2-01 |
2016-6-30 |
|
| Tlr8 transgenic animals |
2015-4-23 |
2016-1-07 |
|
| Chimeric immunomodulatory compounds and methods of using the same-iv |
2015-4-22 |
2015-10-22 |
|
| Methods and compositions for inhibition of immune responses and autoimmunity |
2015-2-03 |
2015-10-01 |
|
| Methods of treatment using tlr7 and/or tlr9 inhibitors |
2014-11-25 |
2015-7-23 |
|
| Long term disease modification using immunostimulatory oligonucleotide |
2014-10-03 |
2015-2-12 |
|
| Long term disease modification using immunostimulatory oligonucleotides |
2014-7-18 |
2016-5-10 |
2016-5-10 |
| Methods and compositions for inhibition of innate immune responses and … |
2014-6-23 |
2015-2-19 |
|
| Human toll-like receptor inhibitors and methods of use thereof |
2013-9-27 |
2018-1-16 |
2018-1-16 |
| CHEMICAL ADMINISTRATIVE UNIONS AND METHODS OF USING THEM |
2013-8-08 |
2016-12-14 |
|
| Human toll-like receptor inhibitors and methods of use thereof |
2013-4-11 |
2014-4-24 |
|
| Methods of treatment using TLR7 and/or TLR9 inhibitors |
2013-4-11 |
2013-5-02 |
|
| METHODS AND COMPOSITIONS FOR SUSPENSION OF IMMUNE AND IMMEDIATE RESPONSE |
2012-9-04 |
2017-1-04 |
|
| Compositions comprising structurally stable conjugate molecules |
2012-5-18 |
2014-10-14 |
2014-10-14 |
| Sequences of immunoglobulin oligonucleotides and their methods of use |
2012-4-25 |
2016-2-10 |
|
| Compositions and methods of making and using influenza proteins |
2012-3-26 |
2013-4-11 |
|
| Binding agents with specificity for a nucleic acid modification |
2012-2-16 |
2012-8-23 |
|
| Biodegradable immunomodulatory formulations and methods for use thereof |
2012-1-25 |
2014-3-11 |
2014-3-11 |
| Methods and compositions for eliciting an immune response against hepatitis B … |
2011-4-04 |
2013-2-14 |
|
| Methods of treatment using tlr7 and/or tlr9 inhibitors |
2010-12-14 |
2011-12-22 |
|
| Methods and compositions for induction or promotion of immune tolerance |
2010-8-12 |
2011-5-26 |
|
| Methods of reducing papillomavirus infection using immunomodulatory … |
2010-2-05 |
2010-7-22 |
|
| Methods of preventing and treating respiratory viral infection using … |
2009-7-28 |
2010-2-11 |
|
| Heterogeneous synthesis of multivalent chimeric immunomodulatory compounds … |
2009-6-30 |
2010-1-07 |
|
| Immunomodulatory compositions, formulations, and methods for use thereof |
2009-3-02 |
2013-11-19 |
2013-11-19 |
| Inhibition of type i ifn production |
2008-10-30 |
2009-5-07 |
|
| Immunomodulatory polynucleotides and methods of using the same |
2007-12-21 |
2013-2-12 |
2013-2-12 |
| Immunomodulatory formulations and methods for use thereof |
2007-2-07 |
2007-11-08 |
|
| Methods of ameliorating symptoms of herpes infection using immunomodulatory … |
2006-11-10 |
2007-3-15 |
|
| Immunostimulatory sequence oligonucleotides and methods of using the same |
2003-12-18 |
2012-5-31 |
|
| Branched immunomodulatory compounds and methods of using the same |
2003-12-17 |
2008-9-04 |
2008-9-04 |
| Immunomodulatory compositions comprising a cationic condensing agent, an … |
2003-8-12 |
2011-7-28 |
|
| Chimeric immunomodulatory compounds and methods of using the same-IV |
2003-7-18 |
2004-7-08 |
|
| Methods of suppressing hepatitis virus infection using immunomodulatory … |
2003-2-03 |
2010-6-01 |
2010-6-01 |
| Chimeric immunomodulatory compounds and methods of using the same - III |
2002-12-23 |
2003-12-04 |
|
| Immunomodulatory compositions, formulations, and methods for use thereof |
2002-8-07 |
2003-6-19 |
|
| Chimeric immunomodulatory compounds and methods of using the same |
2002-6-21 |
2003-6-19 |
|
| Immunomodulatory oligonnucleotide formulations and methods for use thereof |
2001-8-13 |
2003-5-29 |
|
| Immunomodulatory oligonucleotide formulations and methods for use thereof |
2001-8-13 |
2004-5-06 |
|
| Methods of preventing and treating viral infections using immunomodulatory … |
2001-3-12 |
2001-9-24 |
|
| Immunostimulatory polynucleotide sequences for use in preventing and treating … |
2001-3-12 |
2001-12-06 |
|
| Biodegradable immunomodulatory formulations and methods for use thereof |
2001-3-12 |
2001-12-06 |
|
| Methods of preventing and treating respiratory viral infection using … |
2001-3-12 |
2001-12-06 |
|
| Immunomodulatory formulations and methods for use thereof |
2001-3-12 |
2001-12-06 |
|
| Immunostimulatory polynucleotide sequences for use in preventing and treating … |
2001-3-12 |
2001-12-06 |
|
| Immunostimulatory polynucleotide sequences for use in suppressing hepatitis … |
2001-3-12 |
2001-12-06 |
|
| Treatment of herpes infection using immunomodulatory polynucleotide sequences |
2001-3-12 |
2001-12-06 |
|